PURPOSE. We recently reported that SERPINA3K (SA3K), a member of the serine proteinase inhibitor (SERPIN) family, has antiangiogenic and anti-inflammatory activities. Here we investigated the antioxidant effects of SA3K in the corneal epithelium and the mechanism underlying its action.
METHODS.
We established the oxidative stress models induced by hydrogen peroxide (H 2 O 2 ) in cultured human corneal epithelial (HCE) cells and in rat corneal epithelium in vivo. Cell viability, flow cytometry, and TUNEL analysis were conducted to detect viable cells and cell death; reactive oxygen species (ROS) and 3-Nitrotyrosine fluorescent assay was applied to measure ROS levels. Activity assay, immunostaining, Western blot, and quantitative RT-PCR were performed to analyze the factors of the ROS generation/degradation system and pathway.
RESULTS. SA3K protected the HCE cells from H 2 O 2 -induced oxidative stress in a dose-and time-dependent manner. SA3K also significantly reduced the production of ROS. Regarding the mechanism underlying these effects, SA3K downregulated ROS generation by inhibiting NOX4 and upregulated ROS degradation by increasing the activity of superoxide dismutases and catalase. Furthermore, H 2 O 2 induced activation of the Kelch-like ECH-associated protein 1 (KEAP1)/NF-E2-related factor-2 (NRF2) pathway, while SA3K inhibited H 2 O 2 -induced activation of KEAP1 and NRF2 and their downstream factors, including NAD(P)H quinone oxidoreductase and glutathione Stransferase. In the H 2 O 2 -induced rat corneal epithelium , SA3K alleviated the oxidative stress and downregulated NOX4 and NRF2.
CONCLUSIONS. Collectively, SA3K protects against oxidative stress by targeting the ROS generation/degradation system and modulating the KEAP1-NRF2 signaling pathway. (Invest Ophthalmol Vis Sci. 2012;53:5033-5043) DOI:10.1167/ iovs.12-9729 I t is known that the excess formation of reactive oxygen species (ROS) products, in a state of oxidative stress, contributes to the pathogenesis of multiple diseases, for example, neurodegenerative diseases, cancer, diabetes, and vascular disorders. [1] [2] [3] [4] Oxidative stress also becomes an important target of some pharmacologic interventions. 5 These ROS products mainly include superoxide anion (O 2 À ), hydroxyl radical (
. OH), and hydrogen peroxide (H 2 O 2 ). 3-Nitrotyrosine (3-NT) has also been considered a byproduct of ROS. 6 Oxidative stress is believed to play an important role in several ocular diseases including Fuchs' endothelial corneal dystrophy, [7] [8] [9] keratoconus, and others. 10 It has been reported that 3-NT is expressed in certain corneal diseases, such as keratoconus and Fuchs' corneal dystrophy. 6 In experimental research, H 2 O 2 , one of the main ROS products, has been often applied and investigated as a useful oxidative stress model. 5 The NOX family of NADPH oxidase, a main ROS generation factor, has been intensively studied, since these components of the ROS system may play roles in the pathogenesis of diseases. Six NOX family members have been identified so far, namely, NOX1, NOX3, NOX4, NOX5, DUOX1, and DUOX2. [11] [12] [13] [14] NOX4 is found in the macrophage at the start of inflammation and is believed to be involved in the generation of H 2 O 2 . 15, 16 There is a balance between ROS generation (pro-oxidants, i.e., NADPH oxidase) and ROS degradation (antioxidants, e.g., superoxide dismutases [SODs] and catalase) in the cells. Both excess of NADPH oxidase-derived ROS or dysfunction of antioxidant enzyme can result in an abnormal oxidative stress state. 17 NF-E2-related factor-2 (NRF2) is a transcription factor. 18, 19 Lately, the research on the function and mechanism of NRF2 has drawn a lot of attention and recently, suboptimal NRF2 function has been suggested to play a key role in some of the ocular diseases, namely Fuchs' endothelial corneal dystrophy. 10 When the cell is not under oxidative stress, NRF2 is bound to Kelch-like ECH-associated protein 1 (KEAP1), forming a structural complex, the KEAP1-NRF2 complex. KEAP1 inhibits the activity of NRF2 and accelerates the degradation of NFR2. The binding site of NRF2 to KEAP1has been identified. 20, 21 When the cell is under the stimulation of oxidative stress, the KEAP1-NRF2 complex dissociates, leading to NRF2 accumulation in the cytoplasm and NRF2 translocation into the nucleus; this initiates phase 2 of the antioxidant response element (ARE) system, which plays an antioxidant role by activating the downstream antioxidant factor genes, such as quinone oxidoreductase (NQO1) and glutathione S-transferase (GSTP). [22] [23] [24] This signaling pathway is also called KEAP1-NRF2 or KEAP1-NRF2-ARE pathway. SERPINA3K (SA3K), a member of the serine proteinase inhibitor (SERPIN) family, also known as kallikrein-binding protein, was first identified as a specific inhibitor of tissue kallikrein, as it specifically binds with tissue kallikrein to form a covalent complex and inhibits its proteolytic activities. 25 It is expressed in the liver, kidney, and ocular tissues. It has been recently shown that SA3K has antineovascularization, antiinflammation, and antioxidative stress effects in the retina. [26] [27] [28] It has lately been reported that SA3K, as an inhibitor of Wnt pathway, plays a unifying role in its antiangiogenesis and antiinflammatory effects. 29 We have recently shown that SA3K has antiangiogenic and anti-inflammatory effects on the corneal injury. 30 To evaluate the antioxidant effect of SA3K in this present study, we examined the protective effects of SA3K against H 2 O 2 -induced oxidative stress and investigated its underlying mechanism on ROS signaling, by focusing on ROS generation, that is, NOX4, and ROS degradation, that is, SOD, catalase, as well as the KEAP1-NRF2 pathway and its downstream ARE family factors.
MATERIALS AND METHODS

Materials
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] and Sulforaphane (SFN) were purchased from Sigma (Saint Louis, MO). The CCK-8 assay kits were purchased from Dojindo, Tokyo, Japan. AlexaFluor488-conjugated IgG was purchased from Invitrogen (Carlsbad, CA). The antibodies anti-NOX4, anti-KEAP1, anti-NRF2, anti-3NT, and anti-NQO1 were purchased from Abcam (Cambridge, MA). Annexin-V/FITC and Propidium Iodide kit was purchased from Nanjing Kaiji Inc., Nanjing, China. ROS assay kits, SOD assay kits, catalase detection kit, and TUNEL kit were purchased from Beyotime Biotechnology, Haimen, China.
Purification of SA3K
The SA3K/pET28 construct was introduced into Escherichia coli strain BL21. The purification procedure of SA3K has been previously reported. 30 The purity of recombinant SA3K was examined by SDS-PAGE. Endotoxin concentration was monitored by using a limulus amebocyte kit. Activity was checked by MTT assay with HUVEC cells.
Cell Culture and Procedures
Human corneal epithelial (HCE) cells, simian virus 40 transformed, were obtained from RIKEN Biosource Center, Tokyo, Japan, and were passaged in supplemented hormonal epithelial medium (SHEM), which comprises DMEM-F12 supplemented with 6% heat-inactivated fetal bovine serum, bovine insulin (5 lg/mL), recombinant human epidermal growth factor (10 ng/mL), and 1% penicillin and streptomycin. To establish experimental settings for oxidative stress, H 2 O 2 at different concentrations of 0.05 mM, 0.1 mM, and 0.25 mM was added as conditioned medium for treatment of 4 hours, 24 hours, or the time specifically mentioned, respectively; simultaneously, SA3K and other agents were given in the treated groups. For MTT assay and CCK-8 assay experiments, the HCE cells were plated at a density of 1 3 10 4 cells per well in 96-well culture plates. When the HCE cells were cultured to 70% confluency, the medium was removed and changed in the presence of H 2 O 2 or SA3K at a specific concentration and in the absence of H 2 O 2 or SA3K. For all other experiments, the HCE cells were plated at a density of 1 3 10 4 cells per well in 6-well or 24-well culture plates. When the HCE cells were cultured to 70% confluency, the medium was removed and changed in the presence of H 2 O 2 or SA3K at a specific concentration and in the absence of H 2 O 2 or SA3K. The SFN treatment experiment setting was as follows: when the HCE cells were cultured to 70% confluency, the medium was removed and changed in the presence of SFN or SA3K at specific concentration and in the absence of SFN or SA3K. After treatment for a specified time period, the cells were harvested or prepared for MTT assay/CCK-8 assay, flow cytometry analysis, ROS assay, SOD activity assay, catalase activity assay, fluorescent staining, immunofluoresent staining, Western blot, and quantitative real-time PCR analysis following the methods and procedures described below.
In Vivo Experimental Procedures
The experimental rats were purchased from Shanghai Shilaike Laboratory Animal Co., Ltd., Shanghai, China. The animal experiments were carefully performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and the animal experimental protocol was approved by the Animal Experimental Committee of Xiamen University (approval ID: XMUMC2010-03-2).
The animals were kept in the air conditioned facility, with food and water ad libitum.
Wistar rats (male, 180-220 g) were randomly divided into four groups (n ¼ 5): (1) control group without any treatment; (2) positive control groups, that is, H 2 O 2 plus PBS only group, (3) H 2 O 2 plus BSA group, and (4) SA3K treatment group, that is, H 2 O 2 plus SA3K group. Two experimental settings were applied from the pilot study. One procedure was as follows: The rats were anesthetized with pentobarbital (50 mg/kg IP), then 10 lL H 2 O 2 (500 lM) was topically administered. After 30 minutes, 10 lL PBS only, 10 lL BSA (10 lg in PBS), or 10 lL SA3K (10 lg in PBS) was topically given. After 4 hours, rats were sacrificed, followed by removal and dissection of the eyeballs. The dissected eyeballs were stored in a À808C freezer for the use of histologic and immunofluorescent staining, fluorescent staining, or Western blot analysis. The other procedure was as follows: The rats were anesthetized with pentobarbital (50 mg/kg IP), then 10 lL H 2 O 2 (500 lM) was topically administered. After 30 minutes, 10 lL PBS only, 10 lL BSA (10 lg in PBS), or 10 lL SA3K (10 lg in PBS) was topically given. After 12 hours, 10 lL PBS, 10 lg BSA, or 10 lg SA3K was topically placed again. After 24 hours rats were sacrificed, followed by removal and dissection of the eyeballs. The dissected eyeballs were stored in a À808C freezer for the use of histologic and immunofluorescent staining, fluorescent staining or Western blot analysis. The dissection of corneal tissue for Western blot was as follows: the whole corneal tissue, including approximately 0.5-mm-width limbal area, was carefully dissected with surgical scissors under a surgical microscope by an experienced person.
MTT Assay/CCK-8 Assay
The cultured HCE cells were used. The MTT assay and CCK-8 assay were conducted with the protocol of the manufacturer. Briefly, after incubation in conditional media for a specified time period, the media was replaced by MTT or CCK-8 constituted in culture media, followed by incubation for 4 hours at 378C in the dark. For MTT assay, the MTT solution was removed after incubation and the MTT-formazan products were extracted with 100 lL dimethyl sulfoxide in the dark at room temperature, followed by measurement. For the CCK-8 assay, the solution was detected directly after incubation. The absorbance was measured spectrophotometrically at 570 nm with a Bio Tek ELX800 microplate reader (Bio-Tek Instruments, Winooski, VT).
Flow Cytometry Analysis
The cultured HCE cells were used. Twenty-four hours after the treatment of growth medium or the conditioned medium containing H 2 O 2 or SA3K, the HCE cells were washed with PBS once, then harvested and stained with the Annexin-V/FITC and Propidium Iodide by using the kit and following the protocol recommended by the manufacturer. The apoptotic cells were measured from the flow cytometry profile. 31 The samples were analyzed to quantify apoptotic cells and cell viability by flow cytometry.
ROS Assay
The cultured HCE cells were used. ROS levels were measured by following the protocol of the manufacturer. Briefly, changes in intracellular ROS levels were determined by measuring the oxidative conversion of cell permeable 2 0 ,7 0 -dichlorofluorescein diacetate (DCFH-DA) to fluorescent dichlorofluorescein (DCF). Cells in 24-well culture dishes were washed once with PBS and then were incubated with DCFH-DA at 378C for 30 minutes. DCF fluorescence distribution of 5000 cells was detected by flow cytometric analysis at an excitation wavelength of 488 nm and at an emission wavelength of 525 nm.
SOD Activity Assay
The cultured HCE cells were used. SOD activity was measured by following the protocol of the manufacturer. Briefly, it measured the formation of a formazan dye upon reduction of the tetrazolium salt razolium) with superoxide anions. This mixture of the supernatant and enzyme working solution was incubated for 20 minutes at 378C and the absorbance was read at 450 nm. For the data analysis, the activity was calculated in units and was divided by the amount of protein measured.
Catalase Activity Assay
The cultured HCE cells were used. Catalase activity was detected by following the protocol of the manufacturer. The colorimetric method has been described previously. 32 For the data analysis, the activity was calculated in units and was divided by the amount of protein measured.
Autofluorescent Assay and Immunofluorescent Staining
After the HCE cells were incubated for the ROS assay for 30 minutes, the autofluorescent ROS expression of cells was detected by a laser fluorescent microscope and the photographic images were taken. For the immunofluorescent staining with anti-3NT, anti-NOX4, anti-KEAP1, and anti-NRF2 antibodies, the HCE cells were fixed in 4% paraformaldehyde for 2 hours and then kept in 70% ethanol for use. The HCE cells or the corneal sections were incubated with anti-3NT antibody (1:400), anti-NOX4 antibody (1:400), anti-KEAP1 antibody, (1:400) and anti-NRF2 antibody (1:400) at 48C overnight. After further incubation in AlexaFluor488-conjugated IgG (1:1000), sections were counterstained with 4,6-diamino-2-phenylindole (DAPI), mounted, and photographed by using a confocal laser scanning microscope (Fluoview 1000; Olympus, Tokyo, Japan).
TUNEL fluorescent staining was conducted by following the protocol of the manufacturer.
Western Blot
Total cellular proteins of the harvested HCE cells or dissected corneal tissues were extracted. The standard Western blot assay protocol was applied. The specific primary antibodies anti-3-NT, anti-NOX4, anti-NRF2, and anti-NQO1, and a horseradish peroxidase-conjugated secondary antibody, were used. Finally, the specific bands were visualized by enhanced chemiluminescence reagents and recorded on film. The subcellular fractions including cytoplasmic, nuclear, and membrane fractions were separated and prepared from the corneal tissues; each fraction was identified by the markers; and then anti-NRF2 in the nuclear fraction was examined by Western blot analysis.
RNA Isolation and Quantitative RT-PCR
Total RNA was extracted from the cultured HCE cells by using TRIzol reagent (Invitrogen). Reverse transcription was performed with Oligo 18T primers and reverse transcription reagents according to the manufacturer's protocol (TaKaRa, Shiga, Japan). Quantitative real-time PCR was performed with mRNA special primers. The following primers were used for the PCR: for SOD2, 5 0 -GAGAAGTACCAGGAGGCGTTG-3 0 (forward) and 5 0 -GAGCCTTGGACACCAACAGAT-3 0 (reverse); for catalase, 5
0 -ACTGAGGTCCACCCTGACTAC-3 0 (forward) and 5 0 -TCGCATTCTTAGGCTTCTCA-3 0 (reverse); for GSTP, 5 0 -GCTCTATGG-GAAGGACCAG-3 0 (forward) and 5 0 -CTCAAAAGGCTTCAGTTGC-3 0 (reverse). PCR reactions were performed on a BIO-RAD CFX-96 Real Time system with SYBR Premix Ex Taq (TaKaRa) at 958C for 10 minutes, followed by 45 cycles of 958C for 10 seconds, 578C for 30 seconds, and 758C for 10 seconds, after which melt curve analysis was performed at once from 658C to 958C. All reactions were performed in triplicate and the average Ct values greater than 38 were treated as negative.
Statistical Analysis
One-way analysis of variance test was conducted to analyze the data from MTT/CCK-8 assay, flow cytometry, ROS assay, SOD activity assay, catalase activity assay, Western blot, and quantitative real-time PCR, followed by a post hoc analysis Tukey test to compare the differences between the groups or a Student's t-test. P < 0.05 was considered statistically significant.
RESULTS
SA3K Protected against H 2 O 2 -Induced Cell Loss in Cultured HCE Cells
To determine if SA3K has protective effects against oxidative stress, we used H 2 O 2 as an oxidative stressor. Briefly, cultured HCE cells were exposed to the medium containing H 2 O 2 for a specified time period. As shown by the measurement of cell viability with the MTT assay, the number of viable HCE cells was significantly decreased after exposure to 0.25 mM H 2 O 2 for 24 hours, as compared with the control group. SA3K at concentrations of 40, 80, 160 and 320 nM increased the cell viability of cultured HCE cells treated by H 2 O 2 in a concentration-dependent manner (Fig. 1A) . In another separate experiment of the HCE cell viability measured by CCK-8 assay, SA3K at concentrations of 80 and 160 nM increased the cell viability of the HCE cells in a time-dependent manner after exposure to H 2 O 2 at a concentration of 0.05 mM at time points of 2, 4, 8, 16, and 24 hours, with statistically significant changes at time points of 4 and 8 hours (Fig. 1B) .
To further confirm the protective effects of SA3K against H 2 O 2 induction, we also conducted flow cytometry detection and TUNEL fluorescent staining to quantify dead cells among the cultured HCE cells. We demonstrated that SA3K at concentrations of 40, 80, 160, and 320 nM increased the number of viable cells and decreased the number of apoptotic cells induced by 0.25 mM H 2 O 2 after 24-hour treatment in a concentration-dependent manner (Figs. 1C, 1D ). On the other hand, in another separate experiment, SA3K at a concentration of 160 nM decreased the number of TUNEL positive-staining cells induced by 0.1 mM H 2 O 2 after 24-hour treatment (Fig.  1E) . Taken together, these results suggest that SA3K protects the HCE cells and reduces cell death caused by oxidative stress induced by H 2 O 2 .
SA3K Suppressed the Production of ROS
To examine the level of ROS in the oxidative stress setting that we established and the effects of SA3K, we measured both the generation of ROS by autofluorescent image detection and the quantification of ROS production. An exposure to H 2 O 2 at a concentration of 0.25 mM for 24 hours resulted in high levels of ROS as shown by examination of the autofluorescent image ( Fig. 2A, green color, as arrow indicates) , whereas SA3K at a concentration of 80 nM significantly suppressed the production of ROS, indicating the antioxidant effect of SA3K (Fig. 2A) . In a consistent result, a different quantitative measurement showed that ROS production was significantly increased in the H 2 O 2 -treated group (0.1 mM, 24 hours) as compared to the control group (Fig. 2B) . Meanwhile, SA3K at a concentration of 80 nM significantly blocked the production of ROS (Fig. 2B) , suggesting that SA3K suppressed ROS production under the oxidative stress induced by H 2 O 2 .
SA3K Inhibited an Oxidant Enzyme
To investigate the mechanism underlying the antioxidant effect of SA3K, we focused on the system of ROS generation and ROS degradation. NOX4 is an isoform of NADPH oxidase, which is well recognized as the main factor of ROS generation. We examined the expression of NOX4 in the oxidative stress model induced by H 2 O 2 and the effects of SA3K by using immunofluorescent staining and Western blot analysis with an anti-NOX4 antibody.
As shown by the immunofluorescent staining, an exposure to H 2 O 2 at a concentration of 0.1 mM for 4 hours resulted in a strong expression of NOX4 in the cytoplasm as well as the nuclear membranes of the cultured HCE cells, while SA3K at a concentration of 80 nM suppressed the expression of NOX4 in HCE cells after exposure to H 2 O 2 (Fig. 3A, green 
SA3K Upregulated ROS Degradation
It is well documented that there are several ROS-degrading or antioxidant enzymes in cells, such as SOD and catalase. To determine if SA3K targets ROS degradation, we measured the enzyme activities and gene expression of SOD and catalase in the H 2 O 2 -induced oxidative stress setting.
It was revealed that the SOD activity of the cultured HCE cells was significantly reduced in the H 2 O 2 -treated group at a concentration of 0.25 mM after 24-hour treatment, as compared to the control group; meanwhile, SA3K at a concentration of 80 nM significantly increased SOD activity in the cells after exposure to H 2 O 2 (Fig. 4A) . On the other hand, in a separate experiment with quantitative real-time PCR assay, gene expression of SOD2 in the HCE cells was significantly downregulated after exposure to 0.1 mM H 2 O 2 for 24 hours, while SA3K at a concentration of 80 nM upregulated the gene expression of SOD2 (Fig. 4B) .
In addition, the catalase activity assay showed that catalase activity was decreased in the group after exposure to H 2 O 2 at a concentration of 0.25 mM for 24 hours, while SA3K at a concentration of 80 nM significantly upregulated the catalase activity induced by H 2 O 2 (Fig. 4C) . Quantitative real-time PCR assay also showed that the gene expression of catalase in the cultured HCE cells was significantly inhibited after exposure to 0.1 mM H 2 O 2 for 24 hours, whereas SA3K at a concentration of 80 nM significantly upregulated the gene expression of catalase (Fig. 4D) .
These above experimental results suggested that SA3K targets the ROS generation/degradation systems by suppressing ROS generation while upregulating the activity of ROS degradation/antioxidant enzymes.
SA3K Modulated the KEAP1-NRF2 Pathway
To further investigate the mechanism underlying the antioxidant activity of SA3K, we evaluated the effect of SA3K on the KEAP1/NRF2 pathway-which is believed to play important roles in modulating the redox system-by measuring the key components of the KEAP1-NRF2-ARE pathway at the protein level and gene expression level.
Immunofluorescent staining with the anti-KEAP1 antibody showed that exposure to H 2 O 2 (0.1 mM, 24 hours) resulted in an intensive immunosignal of KEAP1 in the cytoplasm as well as the nucleus of HCE cells (Fig. 5A ), indicating that KEAP1 was activated by treatment with H 2 O 2 , which was followed by nuclear translocation of KEAP1. Meanwhile, SA3K at a concentration of 160 nM suppressed the immunosignals of KEAP1 both in the cytoplasm and the nucleus (Fig. 5A , red color for KEAP1 staining, blue color for DAPI nuclear staining).
Immunofluorescent staining using the anti-NRF2 antibody showed that exposure to H 2 O 2 (0.1 mM, 24 hours) substantially increased intensity of NRF2 staining in the cultured HCE cells; SA3K at a concentration of 80 nM inhibited the expression of NRF2 (Fig. 5B , green color for NRF2 staining, blue color for DAPI nuclear staining). Interestingly, Western blot analysis of the nuclear fraction, using the anti-NRF2 antibody, revealed that the NRF2 level in the nucleus was elevated in the H 2 O 2 -treated HCE cells (0.1 mM, 24 hours), whereas SA3K at 80 nM downregulated the NRF2 level in the nucleus of the HCE cells after exposure to H 2 O 2 (Fig. 5C ).
In addition, we also found through Western blot analysis that the level of NQO1, a key downstream factor of the KEAP1-NFR2-ARE pathway, was significantly increased after exposure to H 2 O 2 (0.1 mM, 24 hours), while SA3K at a concentration of 80 nM suppressed the NQO1 level after treatment of H 2 O 2 (Figs. 5D, 5E) .
To examine the gene expression alteration regulated by the KEAP1-NRF2 pathway, we measured the gene expression of GSTP, which is considered to be a key downstream component of the KEAP1-NRF2 pathway or of phase 2 of the ARE family, by (Fig. 5F ).
To further elucidate the mechanism of how SA3K mediates NRF2, we established treatment with SFN and selected the concentration of 10 lM SFN in cultured HCE cells after a pilot study. SFN is an inhibitor of KEAP1 and can disassociate the KEAP1-NRF2 complex, which eventually results in the accumulation of NRF2 in cells. 20 It was demonstrated that treatment with 10 lM SFN for 24 hours decreased cell viability significantly (see Supplementary Material and Supplementary Taken together, these results suggest that the KEAP1-NRF2 pathway is activated by H 2 O 2, whereas SA3K blocks H 2 O 2 -induced activation of the KEAP1-NRF2 pathway by suppressing the protein level or gene expression of NRF2, as well as the downstream factors of the KEAP1-NRF2-ARE pathway, NQO1 and GSTP.
SA3K Had Antioxidant Effects in the Rat Corneal Epithelium
To examine the antioxidant effect of SA3K on the corneal epithelium and the mechanism of SA3K in in vivo conditions, we established an oxidative stress setting by topical administration of 500 lM H 2 O 2 to rat eyes. The histologic staining, immunostaining, and Western blot analysis were conducted after 4 and 24 hours.
The histologic hematoxylin and eosin (H&E) staining showed that the surface of the corneal epithelium layer was mildly damaged and the thickness of the stroma layer was increased after treatment with 500 lM H 2 O 2 for 24 hours, but no significant damage or inflammation was observed; on the other hand, SA3K at 20 lg/eye/day ameliorated this mild damage in the corneal epithelial layer (Fig. 6A , the top row of images, arrows indicate mildly damaged surface). It was also revealed that TUNEL positive-staining cells in the corneal epithelium increased after exposed to H 2 O 2 , while SA3K at 20 lg/eye/day decreased the number of TUNEL-positive cells, suggesting that SA3K alleviated cell death induced by oxidative stress in rat corneal epithelium (Fig. 6A , the second row of images). In addition, immunofluorescence staining using the anti-3NT antibody, a widely used marker of oxidative stress, showed that the level of 3-NT was increased in the corneal epithelium after exposure to H 2 O 2 , while SA3K at 20 lg/eye/ day suppressed 3-NT expression, indicating that SA3K has an antioxidant effect on the corneal epithelium in vivo (Fig. 6A , the third row of images). Furthermore, the immunofluorescence staining of anti-NOX4 antibody also revealed that the level of NOX4 was increased in the corneal epithelium after exposure to H 2 O 2 , while SA3K at 20 lg/eye/day inhibited the NOX4 expression, suggesting that SA3K suppressed the generation of oxidative stress (Fig. 6A , the bottom row of images).
To further confirm the ROS expression changes and to study the mechanism of SA3K on ROS pathway in rat corneal epithelium, we conducted Western blot analysis with the anti-3NT and anti-NRF2 antibodies. It was demonstrated that the level of 3-NT in the rat cornea was significantly upregulated after exposure to 500 lM H 2 O 2 for 4 hours, while SA3K at 10 lg/eye significantly suppressed the 3-NT level (Figs. 6B, 6C ), suggesting that SA3K inhibited the production of ROS in the in vivo model. In addition, the level of NRF2 in the rat cornea was significantly increased after exposure to H 2 O 2 , while SA3K at 10 lg/eye significantly downregulated the NRF2 level (Figs. 6B, 6D ), indicating that SA3K suppressed the key factor of the KEAP1-NRF2 pathway after induction of H 2 O 2 .
Collectively, in the in vivo oxidative stress setting, SA3K also had protective effects on the rat corneal epithelium against oxidative stress by inhibiting the generation of ROS and modulating the KEAP1-NRF2 pathway. These results are consistent with those from the cultured HCE cells.
DISCUSSION
SA3K is a serine proteinase inhibitor. We recently demonstrated that SA3K has antiangiogenesis and anti-inflammatory activity in corneal injury models. 28 In this study we showed for the first time that SA3K has antioxidant effects in the corneal epithelium. Furthermore, we found that these antioxidant effects are exerted through the mediation of ROS generation/degradation and the KEAP1-NRF2 pathway. These studies indicated that SA3K is a novel antioxidant factor in the SERPIN family. These findings will contribute to our understanding of endogenous antioxidant systems and to the development of new therapeutic agents for the oxidative stress-related corneal diseases.
Oxidative stress is a very complex process and involves multiple factors or pathways, such as NOX4 and the KEAP1-NRF2 pathway. Our study suggested that SA3K can target the ROS system, restore the balance of ROS generation and degradation, modulate the KEAP1-NRF2 pathway, and play an antioxidant role.
It is believed that NRF2 is an important transcription factor and plays a key role in the ROS signaling pathway. [18] [19] [20] NRF2 is regulated by KEAP1 and forms a KEAP1-NRF2 complex. KEAP1 binds with Cul3-containing E3 ubiquitin ligase. 24 Under oxidative stress (e.g., exposure to H 2 O 2 ), the Cul3-containing E3 ubiquitin ligase is inhibited, subsequently leading to NRF2 accumulation in the cytoplasm and translocation in the nucleus, as well as activation of ARE-dependent genes, such as NQO1 and GSTP. 20, 21 In the present study, H 2 O 2 induced the expression of KEAP1 in the cytoplasm and nucleus as well as the nuclear translocation of NRF2, followed by activation of NQO1 and GSTP; interestingly, SA3K suppressed the battery of group without any treatment; 3-4, H 2 O 2 (500 lM, 10 lL) plus PBS group; 5-6, H 2 O 2 (500 lM, 10 lL) plus BSA (10 lg/eye) group; and 7-8, H 2 O 2 (500 lM, 10 lL) plus SA3K (10 lg/eye) group. The treatment time was 4 hours. Each band represents an individual rat corneal sample. (C, D) Statistical analysis of anti-3NT antibody and anti-NRF2 antibody Western blot results, respectively (mean 6 SEM, n ¼ 3, *P < 0.05; **P < 0.01).
activities induced by oxidative stress, suggesting that SA3K blocks the early stage of H 2 O 2 -induced activation of the KEAP-NRF2 pathway, inhibits the subsequent activity of the downstream pathway, and restores the balance of the KEAP1-NRF2-ARE pathway from excess levels. The excess accumulation of NRF2 in the cell is considered to be a factor that induces apoptosis and eventually leads to cell protection against oxidative stress. 20, 21 As revealed in Figure S1 (see Supplementary Material and Supplementary Fig. S1 , http://www.iovs.org/ lookup/suppl/doi:10.1167/iovs.12-9729/-/DCSupplemental), it was suggested that SA3K might inhibit the accumulation of NRF2 and protect the HCE cells. We showed that SA3K targets the KEAP1-NRF2 pathway, but further elucidation of the detailed mechanism of SA3K on the KEAP1-NRF2 pathway is needed, including the binding site of the KEAP1-NRF2 complex by SA3K, the interaction between the KEAP1-NRF2-ARE pathway and other signaling pathways, and indirect actions of SA3K on the KEAP1-NRF2-ARE pathway.
We applied an oxidative stress setting in an in vivo condition and suggested that SA3K's antioxidant activity was mediated through the important factors of ROS generation/ degradation systems and pathways, such as NOX4 and NRF2. It will be helpful to further identify the genetic pathogenesis of corneal oxidative stress by using suitable and available ROS transgenic animal models, such as transgenic (Tg-SOD) mice. 33 In our in vivo model, H 2 O 2 may induce the loss of the epithelial barrier function, which then leads to stroma swelling. SA3K ameliorated H 2 O 2 -induced minor injury of epithelium surface, but did not improve the thickness or swelling of the stroma, suggesting that SA3K may not be able to protect from the dysfunction of epithelial barrier induced by H 2 O 2 .
We have previously reported that SA3K blocks the Wnt signaling pathway, which represents a unifying mechanism for its anti-inflammatory, antiangiogenic, and antifibrotic activities. 29 It remains to be investigated whether SA3K's antioxidant activity in the corneal epithelium is through modulation of the Wnt pathway. 34, 35 It is known that oxidative stress is the pathogenesis underlying various ocular diseases, including Fuchs' endothelial corneal dystrophy, 7-9 keratoconus, and others. 10 This study may contribute to better understanding of the oxidative stress state in corneal epithelium cells and reveal a new target for pharmacologic intervention and new antioxidants in the treatment of corneal diseases.
